Psychedelic-assisted therapy as a complex intervention: implications for clinical trial design.

Area of Science:

• Psychopharmacology
• Clinical Psychology
• Health Services Research

Background:

• Psychedelic-assisted therapy (PAT) research often uses conventional randomized controlled trials (RCTs).
• Conventional RCTs may not adequately assess complex interventions like PAT, which involve pharmacological, psychotherapeutic, and contextual factors.
• There is a need for research methodologies that better reflect real-world clinical practice.

Purpose of the Study:

• To advocate for the application of the UK Medical Research Council's (MRC) framework for complex interventions in the development and evaluation of PAT.
• To propose pragmatic trial designs, guided by the PRECIS-2 tool, for more effective PAT research.
• To address philosophical divergences and suggest integrated methodologies for robust PAT evaluation.

Main Methods:

• Advocacy for the MRC framework for complex interventions.
• Proposal of pragmatic trial designs and the PRECIS-2 tool.
• Discussion of integrating qualitative methodologies, adaptive designs, and comparative effectiveness research.

Main Results:

• Conventional RCTs may be insufficient for evaluating complex interventions like PAT.
• Pragmatic trials and the MRC framework offer a better approach for real-world PAT evaluation.
• A pluralistic evidentiary model is needed for rigorous and equitable PAT development.

Conclusions:

• Pragmatic trial designs aligned with the MRC framework are essential for advancing psychedelic-assisted therapy research.
• Integrating diverse methodologies and stakeholder perspectives will enhance the translation of PAT findings into clinical practice.
• A collaborative, pluralistic approach is crucial to avoid past setbacks and ensure the sustainable development of psychedelic therapies.